Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -3.159\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) Cn1c2ccccc2c2nnc(SCC(N)=O)nc21
b) CC(C)S(=O)(=O)c1cnc(-c2cccnc2)nc1N
c) COc1ccc(NS(=O)(=O)c2ccc3oc(Nc4ccc5c(c4)OCCO5)nc3c2)cc1
d) COc1ccccc1Nc1nc(N)nc(CN2CCN(c3ccccc3)CC2)n1
Answer: d. COc1ccccc1Nc1nc(N)nc(CN2CCN(c3ccccc3)CC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1Nc1nc(N)nc(CN2CCN(c3ccccc3)CC2)n1
COc1ccccc1Nc1nc(N)nc(CN2CCN(c3ccccc3)CC2)n1
2-N-(2-methoxyphenyl)-6-[(4-phenylpiperazin-1-yl)methyl]-1,3,5-triazine-2,4-diamine